stockrow
Monday 9 November 2026
Export WHWK’s income statement to Excel — free account
Whitehawk Therapeutics, Inc.
WHWKWhitehawk Therapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $7.1 million, down 72.5% from fiscal 2024.
- Revenue
- +33.5%
- EPS
- +73.7%
- Free cash flow
- +72.6%
Quarter to June 2026, against a year earlier
3.13
0.11
+3.64%
Follow WHWK
Alert me
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
— | — | — | — | — | — | 4 | 3 | 3 | 4 |
P/E ratio |
— | — | 0.00 | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 5.04 |
P/S ratio |
— | — | 0.00 | — | 2.56 | 307.88 | 18.21 | 2.27 | 3.29 | 5.39 |
Altman Z-Score |
— | — | 4.58 | — | (2.10) | 3.46 | 5.17 | (2.36) | (5.80) | 1.52 |
Altman Z″-Score (non-manufacturers) |
— | — | 10.06 | — | (10.94) | 4.63 | 6.29 | (1.35) | (14.66) | 2.98 |
P/FCF ratio |
— | — | 0.00 | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Beneish M-Score |
— | — | — | — | — | — | — | (1.57) | (2.58) | — |
P/Operating CF |
— | — | (9.33) | — | (11.41) | (17.34) | (24.50) | (5.72) | (5.67) | (8.69) |
P/B ratio |
— | — | 0.98 | — | 0.00 | 1.58 | 1.75 | 0.52 | 1.63 | 1.10 |
Price to Tangible BV |
— | — | 0.98 | — | 0.00 | 1.63 | 1.79 | 0.54 | 1.75 | 1.13 |
EV/Sales |
— | — | 0.00 | — | 2.33 | 96.61 | 6.94 | (2.16) | 1.51 | 0.19 |
EV/EBITDA |
— | — | 0.44 | — | 0.00 | 0.00 | 0.00 | 0.70 | 0.00 | 0.00 |
EV/Operating CF |
— | — | 0.84 | — | (2.68) | (3.02) | (2.13) | 0.88 | (0.66) | (0.05) |
EV/FCF |
— | — | 0.84 | — | (2.67) | (3.00) | (2.11) | 0.83 | (0.64) | (0.05) |
Quick Ratio |
0.11 | 5.64 | 11.47 | 11.56 | 0.62 | 9.76 | 9.26 | 4.33 | 3.11 | 10.03 |
Current Ratio |
0.15 | 5.82 | 11.73 | 11.87 | 0.62 | 9.90 | 9.56 | 4.72 | 3.59 | 10.26 |
Net Debt/EBITDA |
0.10 | 0.95 | 5.62 | 1.58 | 1.32 | 4.03 | 2.88 | 1.45 | 0.69 | 1.26 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.17% | 5.85% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | (0.09) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.00 | 0.00 | 0.47 | 0.00 | 0.50 | 0.01 | 0.09 | 0.15 | 0.26 | 0.06 |
Operating CF/Net income |
0.75 | 0.85 | 0.56 | 1.03 | 2.84 | 0.20 | 0.82 | 0.91 | 0.94 | 4.73 |
Capex/Depreciation |
(0.44) | (0.07) | (0.81) | (3.10) | (2.11) | 0.00 | (0.17) | 1.34 | 1.49 | 0.38 |
Interest Coverage |
(34.50) | — | — | (23.71) | (3.13) | (167.24) | (272.53) | (311.40) | (438.04) | — |
| 48.40% | 64.97% | (27.32%) | (48.89%) | (37.05%) | (178.65%) | (41.06%) | (49.90%) | (80.79%) | (21.82%) | |
| (1,731.56%) | (190.77%) | (24.42%) | (44.73%) | (15.20%) | (125.31%) | (35.37%) | (41.54%) | (62.83%) | (18.63%) | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | (804.45%) | 0.00% |
Return on Tangible Assets |
167.54% | (128.31%) | (17.73%) | (63.93%) | 39.33% | (81.39%) | (37.42%) | (63.85%) | (124.74%) | (15.31%) |
Average Days of Receivables |
0.00 | — | 0.00 | — | 354.21 | 0.00 | 44.67 | 82.25 | 82.92 | 0.00 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 88.57% | 0.00% | 102.94% | 1,756.25% | 214.66% | 200.91% | 196.40% | 1,273.10% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 66.90% | 0.00% | 14.55% | 1,652.77% | 264.04% | 182.92% | 141.43% | 417.38% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 17.03% | 0.00% | 0.95% | 188.04% | 63.37% | 49.08% | 41.72% | 138.18% |
Graham Net Nets |
— | — | 1.01 | — | (0.34) | 0.60 | 0.56 | 1.76 | 0.51 | 0.90 |
Graham Number |
— | — | 0.00 | — | 12.40 | 0.00 | 0.00 | 0.00 | 0.00 | 4.88 |
Earnings Yield |
— | — | (24.69%) | — | (9.51%) | (52.58%) | (22.18%) | (119.02%) | (74.37%) | 19.83% |
Free Cash Flow Yield |
— | — | (10.13%) | — | (34.09%) | (10.44%) | (18.07%) | (115.32%) | (71.66%) | (65.43%) |
Revenue per Share |
0.00 | 0.00 | 8.91 | 0.00 | 5.74 | 0.13 | 0.68 | 0.90 | 0.96 | 0.12 |
Operating CF per Share |
(276.24) | (13.06) | (2.57) | (8.81) | (5.00) | (2.51) | (2.21) | (2.22) | (2.20) | (1.57) |
Capex per Share |
(1.99) | (0.01) | (0.02) | (0.09) | (0.01) | (0.01) | (0.02) | (0.15) | (0.06) | (0.01) |
Free Cash Flow per Share |
(278.23) | (13.07) | (2.58) | (8.90) | (5.00) | (2.52) | (2.22) | (2.36) | (2.26) | (1.58) |
Cash per Share |
29.17 | 14.02 | 27.67 | 14.23 | 1.75 | 16.70 | 7.67 | 4.04 | 1.75 | 2.35 |
Shareholders Equity per Share |
(1,515.27) | 12.06 | 25.92 | 13.50 | (4.89) | 15.29 | 7.04 | 3.91 | 1.94 | 2.20 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
(1,515.27) | 12.06 | 25.92 | 13.50 | (4.89) | 15.29 | 7.04 | 3.91 | 1.94 | 2.20 |
Free Cash Flow |
(15.83) | (18.89) | (5.85) | (24.09) | (12.72) | (22.47) | (50.08) | (63.63) | (61.20) | (97.98) |
Working Capital |
(12.63) | 17.31 | 58.53 | 36.24 | (11.37) | 136.00 | 161.19 | 98.19 | 44.21 | 134.49 |
Capital Expenditures |
(0.11) | (0.01) | (0.04) | (0.24) | (0.02) | (0.05) | (0.44) | (3.97) | (1.65) | (0.55) |
Net Current Asset Value |
(86.39) | 17.31 | 58.53 | 36.17 | (12.57) | 129.77 | 154.17 | 97.36 | 43.45 | 134.49 |
EV/EBIT |
— | — | 0.44 | — | 0.00 | 0.00 | 0.00 | 0.73 | 0.00 | 0.00 |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.04 | 0.03 | 0.16 | 0.06 | 0.08 |
Price to Operating Income |
— | — | 0.00 | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
1.73 | 1.18 | 0.47 | 0.47 | 0.43 | 1,302.82 | 5.25 | (0.62) | (0.16) | (482.67) |
Cash ROIC |
18.72% | (50.11%) | (4.82%) | (32.06%) | 185.02% | (7.87%) | (15.13%) | (29.73%) | (61.38%) | (34.75%) |
Accounts Receivable Turnover |
0.00 | — | 0.00 | — | 2.06 | 0.00 | 1.90 | 6.63 | 4.56 | 0.00 |
Accounts Payable Turnover |
0.06 | 0.02 | 0.00 | 0.02 | 0.00 | 0.00 | 0.27 | 0.60 | 0.75 | 0.49 |
Inventory Turnover |
0.00 | 0.00 | — | 0.00 | — | — | 0.00 | 0.68 | 0.52 | 0.00 |
Average Days of Payables |
12,939.96 | 25,558.54 | 0.00 | 15,418.27 | 0.00 | 0.00 | 962.12 | 766.38 | 260.59 | 440.40 |
Days of Inventory on Hand |
0.00 | 0.00 | — | 0.00 | — | — | 508.81 | 835.12 | 641.04 | 0.00 |
Average Receivables |
7.08 | — | — | — | 7.08 | — | 8.01 | 3.68 | 5.70 | — |
Average Payables |
1.24 | 3.03 | 4.52 | 4.34 | 2.81 | 4.42 | 4.98 | 4.71 | 4.03 | 1.54 |
Average Inventory |
— | — | — | — | — | — | — | 4.14 | 5.87 | — |
Average Assets |
1.21 | 11.71 | 42.58 | 52.03 | 29.38 | 88.37 | 171.07 | 158.33 | 101.37 | 110.57 |
Average Common Equity |
(43.20) | (34.39) | 38.05 | 47.60 | 12.05 | 61.99 | 147.39 | 131.79 | 78.84 | 94.39 |
Columns are period end dates · fundamentals updated 26 Oct 2026